Assessment of Growth of Infants Fed an Amino Acid-Based Formula

Mark Corkins1, Laura A Czerkies2, Heidi M Storm2

  • 1Division Chief, Division of Pediatric Gastroenterology, Department of Pediatrics, Le Bonheur Children's Hospital, Memphis, TN, USA.; Professor, Department of Pediatrics, The University of Tennessee Health Science Center, Memphis, TN, USA.

Insights

New amino acid-based formula (AAF) supports infant growth comparably to existing options. This study found no significant differences in daily weight gain for infants fed the test AAF versus a control AAF.

Area of Science:

  • Pediatrics
  • Nutritional Science
  • Infant Nutrition

Background:

  • Amino acid-based formulas (AAFs) are crucial for infants with specific dietary needs.
  • Evaluating the efficacy of novel AAFs is essential for improving infant health outcomes.

Purpose of the Study:

  • To compare the daily weight gain of healthy infants fed a new AAF (Test) against a commercially available AAF (Control).

Main Methods:

  • Randomized controlled trial involving healthy infants from 14 to 112 days of age.
  • Anthropometric measurements and tolerance assessments were conducted throughout the study.
  • Biochemical markers (serum albumin, plasma amino acids) were analyzed in a subset of participants.

Main Results:

  • No statistically significant difference in mean daily weight gain between the Test (27.42 ± 6.37 g/day) and Control (27.26 ± 4.92 g/day) groups (P = 0.8812).
  • Comparable formula intake, adverse events, and tolerance profiles were observed in both groups.
  • Serum albumin and plasma amino acid levels remained within normal physiological ranges for all infants.

Conclusions:

  • The new amino acid-based formula (AAF) demonstrates comparable efficacy to a commercially available AAF in supporting infant growth.
  • The findings support the use of the new AAF as a viable alternative for infant feeding.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
726
Oxygen Requirements and Growth Patterns01:29

Oxygen Requirements and Growth Patterns

Microorganisms exhibit diverse oxygen requirements and growth patterns driven by their metabolic strategies and environmental adaptations. Oxygen, while essential for many organisms, can also be toxic under certain conditions, shaping how microorganisms grow and survive.Oxygen Requirements of MicroorganismsMicroorganisms are classified based on their ability to use or tolerate oxygen:● Obligate aerobes like Mycobacterium tuberculosis need oxygen for energy production, as it serves as the...
2.3K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
693
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.6K
Microbial Growth Measurement: Indirect Methods01:27

Microbial Growth Measurement: Indirect Methods

Estimating microbial growth is essential for understanding population dynamics and environmental adaptations. Indirect methods provide valuable insights by measuring parameters such as turbidity, metabolic activity, and biomass, enabling efficient and reproducible assessments.During exponential growth, microbial cells scatter light proportionally to their biomass, a principle used in turbidity measurements. About one million cells per milliliter produce detectable scattering, which a...
2.3K
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
15